• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞动脉炎(包括颞动脉炎和风湿性多肌痛)的流行病学。不同临床表现和眼部并发症的发病率。

The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.

作者信息

Bengtsson B A, Malmvall B E

出版信息

Arthritis Rheum. 1981 Jul;24(7):899-904. doi: 10.1002/art.1780240706.

DOI:10.1002/art.1780240706
PMID:7259802
Abstract

During a period of three years in Göteborg, Sweden, 126 cases of giant cell arteritis (GCA) were diagnosed. Histologic evidence of arteritis was found on temporal artery biopsy in 74 (59%). The total annual incidence of GCA was calculated to be 9.3 per 100,000 inhabitants. In the age group over 50, incidence was 28.6 per 100,000. For histologically proven GCA, the incidence was 5.5 per 100,000 of the total population. The corresponding figure in the age group over 50 was 16.8 per 100,000. Twenty-six patients (21%) had a clinical presentation of temporal arteritis, and 23 (18%) had a combined picture of temporal arteritis and polymyalgia rheumatica (PMR). Sixty-seven (53%) had the PMR syndrome without any temporal symptoms, and 10 patients (8%) had a "silent" presentation with only general symptoms. The PMR syndrome was more common among women with GCA (79%) than among men (56%). The group of patients without muscular symptoms contained an equal number of men and women. Eye complications were seen in 15 patients (12%). In 6, the ocular symptoms were transient, while 9 suffered from permanent loss of vision. In 3 of these patients, temporal artery biopsy revealed no evidence of arteritis, and 5 had no clinical signs of localized temporal arteritis.

摘要

在瑞典哥德堡的三年时间里,共诊断出126例巨细胞动脉炎(GCA)。74例(59%)颞动脉活检发现动脉炎的组织学证据。GCA的年总发病率经计算为每10万居民中有9.3例。在50岁以上年龄组中,发病率为每10万居民中有28.6例。对于经组织学证实的GCA,在总人口中的发病率为每10万居民中有5.5例。在年龄组50岁以上的相应数字为每10万居民中有16.8例。26例患者(21%)有颞动脉炎的临床表现,23例(18%)有颞动脉炎和风湿性多肌痛(PMR)的合并表现。67例(53%)有PMR综合征但无任何颞部症状,10例患者(8%)有仅伴有全身症状的“无症状”表现。GCA患者中,PMR综合征在女性(79%)中比在男性(56%)中更常见。无肌肉症状的患者组中男女数量相等。15例患者(12%)出现眼部并发症。其中6例眼部症状为短暂性,而9例视力永久性丧失。在这些患者中,3例颞动脉活检未发现动脉炎证据,5例无局限性颞动脉炎的临床体征。

相似文献

1
The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.巨细胞动脉炎(包括颞动脉炎和风湿性多肌痛)的流行病学。不同临床表现和眼部并发症的发病率。
Arthritis Rheum. 1981 Jul;24(7):899-904. doi: 10.1002/art.1780240706.
2
Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden.巨细胞动脉炎患者眼部表现的风险:瑞典的一项全国性研究。
Scand J Rheumatol. 2017 Nov;46(6):484-489. doi: 10.1080/03009742.2016.1266030. Epub 2017 Feb 22.
3
Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.活检证实为巨细胞动脉炎的风湿性多肌痛并不构成一个不同的亚组,而是与孤立性风湿性多肌痛有所不同。
J Rheumatol. 1998 Sep;25(9):1750-5.
4
Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.土耳其西北部的巨细胞动脉炎和风湿性多肌痛:临床特征和流行病学数据。
Clin Exp Rheumatol. 2009 Sep-Oct;27(5):830-3.
5
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.西班牙西北部经活检证实的巨细胞动脉炎的流行病学:18年期间的趋势
Ann Rheum Dis. 2001 Apr;60(4):367-71. doi: 10.1136/ard.60.4.367.
6
The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94.挪威南部奥斯特-阿格德尔郡风湿性多肌痛和颞动脉炎的发病率:一项1987 - 1994年的前瞻性研究
J Rheumatol. 1997 Sep;24(9):1739-43.
7
Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.2015 年巨细胞动脉炎和风湿性多肌痛的当代流行率估计。
Semin Arthritis Rheum. 2017 Oct;47(2):253-256. doi: 10.1016/j.semarthrit.2017.04.001. Epub 2017 Apr 7.
8
Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988.芬兰某地区的巨细胞动脉炎和风湿性多肌痛:一项1984 - 1988年的流行病学、临床及病理学研究
J Rheumatol. 1992 Feb;19(2):273-6.
9
[Synchronous variations in the incidence of temporal arteritis and polymyalgia rheumatica in Danish counties. Association with epidemics of Mycoplasma pneumonia infection].[丹麦各郡颞动脉炎和风湿性多肌痛发病率的同步变化。与肺炎支原体感染流行的关联]
Ugeskr Laeger. 1997 Jun 23;159(26):4123-8.
10
Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection.丹麦不同地区颞动脉炎和风湿性多肌痛发病率的同步变化;与肺炎支原体感染流行的关联。
J Rheumatol. 1996 Jan;23(1):112-9.

引用本文的文献

1
Neuro-ophthalmic Manifestations of Giant Cell Arteritis: A Review.巨细胞动脉炎的神经眼科表现:综述
J Ophthalmic Vis Res. 2025 Jun 24;20. doi: 10.18502/jovr.v20.15248. eCollection 2025.
2
Predictive Factors for Biopsy-Negative Giant Cell Arteritis and Alternative Diagnoses in a Neuro-Ophthalmology Context.神经眼科背景下活检阴性巨细胞动脉炎的预测因素及其他诊断
Neuroophthalmology. 2024 Feb 7;48(4):267-271. doi: 10.1080/01658107.2024.2311131. eCollection 2024.
3
Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis.
巨细胞动脉炎 10 年跨学科队列患者视觉受累的频率。
Clin Med (Lond). 2023 May;23(3):206-212. doi: 10.7861/clinmed.2022-0415. Epub 2023 May 17.
4
Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients.风湿性多肌痛患者巨细胞动脉炎的预测因素
J Clin Med. 2022 Dec 14;11(24):7412. doi: 10.3390/jcm11247412.
5
Giant Cell Arteritis: A Case-Based Narrative Review of the Literature.巨细胞动脉炎:文献案例叙事综述。
Curr Pain Headache Rep. 2022 Oct;26(10):725-740. doi: 10.1007/s11916-022-01075-1. Epub 2022 Sep 3.
6
Global epidemiology of vasculitis.血管炎的全球流行病学。
Nat Rev Rheumatol. 2022 Jan;18(1):22-34. doi: 10.1038/s41584-021-00718-8. Epub 2021 Dec 1.
7
Retinal Detachment and Temporal Artery Dissection: An Elusive Case of Giant Cell Arteritis.视网膜脱离与颞动脉夹层:一例隐匿性巨细胞动脉炎病例
Cureus. 2021 Jul 28;13(7):e16703. doi: 10.7759/cureus.16703. eCollection 2021 Jul.
8
Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis.评估托珠单抗在 80 岁以上巨细胞动脉炎患者中的疗效和安全性。
Arthritis Res Ther. 2021 May 19;23(1):143. doi: 10.1186/s13075-021-02529-4.
9
Characteristics of patients with giant cell arteritis who experience visual symptoms.巨细胞动脉炎出现视觉症状患者的特征。
Rheumatol Int. 2019 Oct;39(10):1789-1796. doi: 10.1007/s00296-019-04422-5. Epub 2019 Aug 22.
10
Arteritic Anterior Ischemic Optic Neuropathy Associated with Giant-Cell Arteritis in Korean Patients: A Retrospective Single-Center Analysis and Review of the Literature.韩国患者中与巨细胞动脉炎相关的动脉炎性前部缺血性视神经病变:一项回顾性单中心分析及文献综述
J Clin Neurol. 2019 Jul;15(3):386-392. doi: 10.3988/jcn.2019.15.3.386.